Kennett Square, PA, United States of America

Gregory M Acland

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 1998-2016

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gregory M Acland

Introduction

Gregory M Acland is a notable inventor based in Kennett Square, Pennsylvania, who has made significant strides in the field of ocular health. With an impressive portfolio of 12 patents, Acland's work primarily focuses on innovative methods for treating ocular disorders, particularly those leading to blindness.

Latest Patents

Acland's most recent patents showcase groundbreaking methods and compositions for treating conditions characterized by genetic defects in ocular cells. One of his latest inventions, titled "Method of Treating or Retarding the Development of Blindness," involves the use of subretinal injections of a recombinant adeno-associated virus. This method is designed to deliver a normal gene's nucleic acid sequence directly to affected ocular cells, specifically targeting retinal pigment epithelial (RPE) cells, to potentially reverse or mitigate the effects of genetic mutations such as RPE65.

Additionally, he has patented tools and methods for identifying dogs predisposed to progressive rod-cone degeneration. This innovation involves genetic testing to determine whether a dog is genetically normal, a carrier, or affected by this ocular condition. A specific transversion detected at a nucleotide position correlates with the disease, providing vital information for breeding and health management in canine populations.

Career Highlights

Throughout his career, Acland has collaborated with esteemed institutions such as the Cornell Research Foundation Inc. and the University of Pennsylvania. His work in these organizations has allowed him to innovate and develop advanced therapeutic approaches that can significantly enhance patient outcomes.

Collaborations

Acland's collaborations have included partnerships with respected colleagues like Gustavo D Aguirre and Orly Goldstein. These collaborations have enriched his research endeavors, fostering an environment where innovative solutions to complex problems in ocular health can emerge.

Conclusion

Gregory M Acland’s contributions to the field of ocular research through his inventive patents demonstrate the profound impact of innovation on health care. His ongoing work continues to pave the way for advancements that could change the lives of individuals affected by genetic ocular disorders, reflecting the critical role of inventors in addressing unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…